Guizhou Chanhen Chemical Past Earnings Performance
Past criteria checks 5/6
Guizhou Chanhen Chemical has been growing earnings at an average annual rate of 36.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 25.1% per year. Guizhou Chanhen Chemical's return on equity is 13.7%, and it has net margins of 18.1%.
Key information
36.6%
Earnings growth rate
32.5%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 25.1% |
| Return on equity | 13.7% |
| Net Margin | 18.1% |
| Next Earnings Update | 10 Apr 2025 |
Recent past performance updates
Recent updates
Estimating The Fair Value Of Guizhou Chanhen Chemical Corporation (SZSE:002895)
Jan 02
Is Guizhou Chanhen Chemical (SZSE:002895) Using Too Much Debt?
Nov 14Here's Why Guizhou Chanhen Chemical (SZSE:002895) Has Caught The Eye Of Investors
Oct 23Returns On Capital Are Showing Encouraging Signs At Guizhou Chanhen Chemical (SZSE:002895)
Oct 08Is Guizhou Chanhen Chemical (SZSE:002895) Using Too Much Debt?
Jul 22Calculating The Fair Value Of Guizhou Chanhen Chemical Corporation (SZSE:002895)
Jul 01Market Still Lacking Some Conviction On Guizhou Chanhen Chemical Corporation (SZSE:002895)
Jun 13Guizhou Chanhen Chemical (SZSE:002895) Is Looking To Continue Growing Its Returns On Capital
May 28Guizhou Chanhen Chemical's (SZSE:002895) Shareholders Will Receive A Bigger Dividend Than Last Year
May 13These 4 Measures Indicate That Guizhou Chanhen Chemical (SZSE:002895) Is Using Debt Extensively
Apr 21Guizhou Chanhen Chemical's (SZSE:002895) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 05Calculating The Intrinsic Value Of Guizhou Chanhen Chemical Corporation (SZSE:002895)
Mar 28Guizhou Chanhen Chemical Corporation (SZSE:002895) Shares Fly 30% But Investors Aren't Buying For Growth
Mar 07Revenue & Expenses Breakdown
How Guizhou Chanhen Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,221 | 947 | 314 | 118 |
| 30 Jun 24 | 4,924 | 847 | 315 | 99 |
| 31 Mar 24 | 4,365 | 743 | 294 | 101 |
| 31 Dec 23 | 4,320 | 766 | 303 | 101 |
| 30 Sep 23 | 4,063 | 660 | 318 | 122 |
| 30 Jun 23 | 3,741 | 661 | 307 | 123 |
| 31 Mar 23 | 3,837 | 813 | 311 | 116 |
| 01 Jan 23 | 3,447 | 759 | 267 | 109 |
| 30 Sep 22 | 3,314 | 746 | 137 | 65 |
| 30 Jun 22 | 3,111 | 634 | 154 | 53 |
| 31 Mar 22 | 2,751 | 438 | 145 | 43 |
| 01 Jan 22 | 2,530 | 368 | 147 | 38 |
| 30 Sep 21 | 2,167 | 212 | 251 | 31 |
| 30 Jun 21 | 1,978 | 164 | 194 | 32 |
| 31 Mar 21 | 1,822 | 152 | 197 | 31 |
| 31 Dec 20 | 1,777 | 143 | 190 | 32 |
| 30 Sep 20 | 1,715 | 181 | 181 | 40 |
| 30 Jun 20 | 1,758 | 207 | 189 | 27 |
| 31 Mar 20 | 1,769 | 201 | 205 | 33 |
| 31 Dec 19 | 1,749 | 180 | 206 | 32 |
| 30 Sep 19 | 1,633 | 153 | 191 | 24 |
| 30 Jun 19 | 1,519 | 104 | 188 | 29 |
| 31 Mar 19 | 1,392 | 78 | 174 | 19 |
| 31 Dec 18 | 1,290 | 77 | 157 | 16 |
| 30 Sep 18 | 1,264 | 72 | 175 | 16 |
| 30 Jun 18 | 1,168 | 73 | 145 | 23 |
| 31 Mar 18 | 1,167 | 106 | 133 | 20 |
| 31 Dec 17 | 1,184 | 133 | 133 | 16 |
| 30 Sep 17 | 1,106 | 131 | 130 | 12 |
| 30 Jun 17 | 1,106 | 143 | 143 | 0 |
| 31 Mar 17 | 1,042 | 119 | 140 | 0 |
| 31 Dec 16 | 1,085 | 122 | 142 | 0 |
| 31 Dec 15 | 1,103 | 117 | 118 | 0 |
| 31 Dec 14 | 845 | 52 | 98 | 0 |
Quality Earnings: 002895 has high quality earnings.
Growing Profit Margin: 002895's current net profit margins (18.1%) are higher than last year (16.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002895's earnings have grown significantly by 36.6% per year over the past 5 years.
Accelerating Growth: 002895's earnings growth over the past year (43.4%) exceeds its 5-year average (36.6% per year).
Earnings vs Industry: 002895 earnings growth over the past year (43.4%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 002895's Return on Equity (13.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 07:21 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guizhou Chanhen Chemical Corporation is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nai Di Zhao | Everbright Securities Co. Ltd. |
| Wei Liu | Haitong International Research Limited |
| Xiaohan Sun | Haitong International Research Limited |